PACLITAXEL

PACLITAXEL

DESCRIPTION

Paclitaxel (PTX), is a plant alkaloid that was developed from the bark of the Pacific Yew Tree, and used to treat a number of types of cancer like ovarian cancer, breast cancer, lung cancer, Kaposi sarcoma, cervical cancer, and pancreatic cancer.

 

 DOSAGE FORM

Paclitaxel Injection
Paclitaxel Liposome Injection
Abraxane
Paclitaxel (natural)
Botanical Source: Taxus chinensis (Pilger) Rehd.CAS No.: 33069-62-4
Specification: CP/EP/BP/USP
Status: GMP available		 Paclitaxel (semi-synthetic)

CAS No.: 33069-62-4
Specification : ≥99%

 

 (4S,5R)-3-Benzoyl-2-
(4-methoxyphenyl)-4-phenyl-5-oxazolidinecarboxylic acid CAS No.: 949023-16-9
Specification : ≥99%
Docetaxel

CAS No.: 114977-28-5
Specification: ≥98%

 

 10-DAB

CAS No.: 32981-86-5
Specification: ≥98%

 7β,10β-diMethoxy-10-deacetylbaccatin III

CAS No.: Specification

CAS No.: 183133-94-0
Specification: ≥99%
Cephalomannine

CAS No.: 71610-00-9
Specification: ≥98%

 Cabazitaxel

CAS No.: 7183133-96-2
Specification: ≥98%

 

 

2018 Exhibition

1. 2018 CPhI Japan                                         18 – 20 April 2018, Tokyo, Japan, Booth No.: U12

2. 2018 Vitafoods Europe                              15 – 17 May 2018, Geneva, Switzerland, Booth No.: E140

3. 2018 CPhI China                                         20 – 22 June 2018, Shanghai, China, Booth No.: E2Q12

4.2018 CPhI Korea                                         28-30 August 2018 Hall D, COEX, Seoul, Korea, Booth No.: F28

5. 2018 CPhI Worldwide                                9 – 11 October 2018, Madrid, Spain, Booth No.: 5F51

6. 2018 SupplySide West                               8 – 9 November 2018, Las Vegas, USA, Booth No.: 2963